Needham & Company hosted its 13th Annual Healthcare Conference on April 8th and 9th in New York City. This year, senior management teams from approximately 120 companies in the biotechnology, specialty pharmaceutical, medical technology and diagnostic sectors were scheduled to present, including a selection of leading private companies. The life sciences sector is enjoying its fourth straight year of outperforming the broader market and has accounted for 80 percent of all venture-backed IPOs so far in 2014. Needham’s Healthcare Conference focused on connecting leading emerging life science companies and investors. One-on-one meetings with companies were available for qualified institutional investors and venture capital firms.